XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net (loss) income $ (118,771,000) $ 5,406,000
Less: Income from discontinued operations, net of tax 0 44,583,000
Loss from continuing operations (118,771,000) (39,177,000)
Adjustments to reconcile loss from continuing operations to net cash (used in) provided by operating activities:    
Change in fair value of contingent consideration 3,200,000 0
Depreciation and amortization 3,177,000 6,437,000
Amortization of deferred financing costs 0 1,428,000
Provision for doubtful accounts 494,000 426,000
Provision for excess and obsolete inventory 10,465,000 0
Impairment of goodwill 11,706,000 0
Impairment of right-of-use assets 7,434,000 0
Impairment of fixed assets 30,178,000 0
Impairment of intangible assets 32,363,000 0
(Gain)/loss on disposal of long-lived assets (668,000) 1,096,000
Non-cash lease expense 299,000 813,000
Stock compensation expense 2,208,000 2,829,000
Deferred income tax provision (199,000) 17,983,000
Reduction in tax benefit related to share-based awards 0 24,000
Changes in current assets and liabilities:    
Accounts receivable, net 4,714,000 21,629,000
Inventories, net 3,186,000 3,000,000
Income taxes receivable (140,000) 2,853,000
Other current assets 823,000 (4,036,000)
Other long-term assets (16,000) 3,286,000
Accounts payable (11,906,000) (4,434,000)
Accrued liabilities (17,689,000) (14,205,000)
Income taxes payable 25,000 595,000
Interest payable 22,000 (8,000)
Net cash (used in) provided by operating activities (39,095,000) 539,000
Cash flows from investing activities:    
Capital expenditures (836,000) (1,869,000)
Proceeds from sale of business 9,907,000 155,498,000
Proceeds from sale of assets 86,000 234,000
Purchase of JP3, net of cash acquired (26,284,000) 0
Purchase of patents and other intangible assets (8,000) (590,000)
Net cash (used in) provided by investing activities (17,135,000) 153,273,000
Cash flows from financing activities:    
Borrowings on revolving credit facility 0 42,984,000
Repayments on revolving credit facility 0 (92,613,000)
Proceeds from Paycheck Protection Program loan 4,788,000 0
Purchase of treasury stock related to share-based awards (123,000) (207,000)
Proceeds from sale of common stock 416,000 7,000
Payments for finance leases (152,000) (51,000)
Net cash provided by (used in) financing activities 4,929,000 (49,880,000)
Discontinued operations:    
Net cash used in operating activities 0 (321,000)
Net cash provided by investing activities 0 337,000
Net cash flows provided by discontinued operations 0 16,000
Effect of changes in exchange rates on cash and cash equivalents (80,000) 2,000
Net (decrease) increase in cash and cash equivalents and restricted cash (51,381,000) 103,950,000
Cash and cash equivalents at the beginning of period 100,575,000 3,044,000
Restricted cash at the beginning of period 663,000 0
Cash and cash equivalents and restricted cash at beginning of period 101,238,000 3,044,000
Cash and cash equivalents at end of period 49,193,000 106,994,000
Restricted cash at the end of period 664,000 663,000
Cash and cash equivalents and restricted cash at the end of period $ 49,857,000 $ 107,657,000